Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study

NCT06249269 is registered in ClinicalTrials.gov with Ratika Parkash as lead sponsor.

NCT NCT06249269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06249269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study
Lead sponsor
Ratika Parkash
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2024
Completion date
March 31, 2027
Enrollment
198 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, paroxysmal or persistent